首页> 外文OA文献 >Use of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea.
【2h】

Use of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea.

机译:使用Epworth嗜睡量表证明阻塞性睡眠呼吸暂停患者对鼻持续气道正压通气治疗的反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Epworth Sleepiness Scale (ESS) was used to measure the degree of daytime sleepiness in two groups of patients with obstructive sleep apnoea (OSA), before and after treatment with nasal continuous positive airways pressure (CPAP). One group (50 patients) were assessed after 2 months CPAP treatment after which the mean ESS fell from 16.4 [standard error of mean (SEM) 0.52] to 7.0 (SEM 0.56). A second group (25 patients) were assessed after 1 yr of treatment: a similar fall in mean ESS was seen from 15.2 (SEM 1.13) before treatment to 6.0 (SEM 0.72). These results imply that the ESS can be used clinically to demonstrate the response of daytime sleepiness in OSA to treatment with CPAP, and that the fall in ESS seen after 2 months is sustained after 1 yr of treatment. It is also possible that this approach could be used to monitor the progress of treatment with CPAP.
机译:爱普华思嗜睡量表(ESS)用于测量两组持续鼻气道正压通气(CPAP)治疗前后阻塞性睡眠呼吸暂停(OSA)患者的白天嗜睡程度。在CPAP治疗2个月后评估了一组(50例患者),之后平均ESS从16.4 [平均标准误(SEM)0.52]降至7.0(SEM 0.56)。治疗1年后评估第二组(25例患者):平均ESS从治疗前的15.2(SEM 1.13)下降至6.0(SEM 0.72)相似。这些结果表明,ESS可在临床上用于证明OSA白天嗜睡对CPAP治疗的反应,并且治疗1年后2个月后ESS持续下降。这种方法也有可能用于监测CPAP的治疗进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号